Table 1.
+Low risk of bias - High risk of bias ? Unclear risk of bias X Not applicable |
Apard (2010) | Donegan (2011) | El Afly (2015) | Gupta (2016) | Olesen (2015) | Stafford (2010) | Giannoudis (2016) | Zoller (2017) | Ma (2017) | Cho (2017) | Sasaki (2018) |
---|---|---|---|---|---|---|---|---|---|---|---|
Were there clear inclusion criteria for the case series? | + | + | + | + | + | + | + | + | + | + | + |
Was the condition measured in a standard, reliable way for all participants included in the case series? | + | + | + | + | + | + | + | + | + | + | + |
Were valid methods used to identify the condition for all participants included in the case series? | + | + | + | + | + | + | + | + | + | + | + |
Did the case series include participants consecutively? | - | + | + | + | + | + | + | + | + | + | - |
Did the case series involve complete inclusion of participants? | - | + | + | + | + | + | + | + | + | + | - |
Was the reporting of the demographics of the participants in the study clear? | + | + | + | + | + | + | + | + | + | + | + |
Was the reporting of the clinical information of the participants clear? | + | + | + | + | + | + | + | + | + | + | + |
Were the outcomes or follow-up results of cases clearly reported? | + | + | + | + | + | + | + | + | + | + | + |
Was the reporting of demographic information of the presenting site(s)/clinic(s) clear? | - | - | - | - | - | - | - | - | - | - | - |
Was the statistical analysis appropriate? | X | X | X | X | X | X | X | X | X | X | X |